Date: 03/22/2022
Product Type: Defect, Drugs
Company Announcement Date: March 21, 2022
FDA Publish Date: March 21, 2022
Product Type: Defect, Drugs
Reason for Announcement: Potential clogging of the needle preventing the dispensing of epinephrine
Company Name: Adamis Pharmaceuticals Corporation
Brand Name: Adamis Pharmaceuticals Corporation
Product Description: SYMJEPI (epinephrine) Injection 0.15 mg (0.15 mg/0.3 mL) and 0.3 mg (0.3 mg/0.3 mL) Pre-Filled Single-Dose Syringes